Bank Of America Corp Cns Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.19 - $292.65 $33 - $51,799	177 New	177 $0
Q1 2022 May 16, 2022	SELL	$0.26 - $1.05 $46 - $185	-177 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$0.7 - $1.54 $3,296 - $7,251	-4,709 Reduced 96.38%	177 $0
Q3 2021 Nov 15, 2021	BUY	$1.4 - $1.98 $4,040 - $5,714	2,886 Added 144.3%	4,886 $7,000
Q2 2021 Sep 13, 2021	BUY	$1.71 - $2.42 $3,420 - $4,840	2,000 New	2,000 $4,000

100

Ticker CNSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,032,500
Market Cap $4.4M
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.